Harry B. Demopoulos

Chairman & Chief Executive Officer at ThyoGen Pharmaceuticals, Inc.

Harry B. Demopoulos

Harry B. Demopoulos

Chairman & Chief Executive Officer at ThyoGen Pharmaceuticals, Inc.

Overview
Career Highlights

ThyoGen Pharmaceuticals, Inc.

RelSci Relationships

343

Number of Boards

5

Number of Awards

1

Relationships
RelSci Relationships are individuals Harry B. Demopoulos likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Doris Duke Charitable Foundation

Relationship likelihood: Strong

Vice President, Programs at Surdna Foundation, Inc.

Relationship likelihood: Strong

Director at National Institutes of Health

Relationship likelihood: Strong

Former Executive Director at Isabella Stewart Gardner Museum

Relationship likelihood: Strong

Founder at The Keffi Group Ltd.

Relationship likelihood: Strong

Co-Founder at East End Advisors LLC

Relationship likelihood: Strong

Executive Director at Robert Rauschenberg Foundation

Relationship likelihood: Strong

Professional at Jornada Basin Long Term Ecological Research

Relationship likelihood: Strong

Former President at Duke University

Relationship likelihood: Strong

Senior Research Scholar at Columbia University - School of International and Public Affairs

Relationship likelihood: Strong

In The News
The New York Times
November 30, 2016
This Season's Books on Sports: A Roundup
Paths to Harry B. Demopoulos
Potential Connections via
Relationship Science
You
Harry B. Demopoulos
Chairman & Chief Executive Officer at ThyoGen Pharmaceuticals, Inc.
Education
MD with Honors
Class of 1956
Memberships
Member
Current

The New York Academy of Sciences is a membership organization with over 25,000 members in 140 countries. They include research scientists at universities and industry, as well as representatives of business, government, and policy organizations. Our Board of Governors and President's Council include 27 Nobel laureates and other prominent leaders of academia and industry, based in New York and around the world.

Career History
Chairman & Chief Executive Officer
Tenure Unconfirmed
Director of Planning, Comprehensive Cancer Center
Prior

NYU School of Medicine has a proud history that goes back to 1837 and includes initiation of and participation in many of the major events in American medicine through two centuries. In 1837, six years after the granting of the first University charter, the minutes of the meetings of the University Council contained the names of men suggested as professors for the chief branches of medical instruction. In 1841, the University Medical College was organized, and instruction was begun under the following: Surgery, Anatomy; Chemistry; Theory and Practice of Medicine; Institutes of Medicine and Materia Medical; Obstetrics and Diseases of Women and Children. Clinical instruction was started in Bellevue Hospital in 1847, and in 1861 Bellevue Hospital Medical College was founded when a college building was erected on the hospital grounds. With the passing of the years and a deepening conviction that the total medical enterprise should be placed in the scholarly setting of the University, it became clear that University Medical College and Bellevue Hospital Medical College would benefit by consolidating. Thus, the medical school became an integral part of New York University in 1898 under the name of University and Bellevue Hospital Medical College. In 1935 the name was changed to New York University College of Medicine and in 1960 to NYU School of Medicine. The School of Medicine celebrated its sesquicentennial year in 1991.

Surgical Pathology
1964 - 1966
Boards & Committees
President, Board of Directors
1980 - 1983
Chairman & Chief Executive Officer
Tenure Unconfirmed
Member, Board of Trustees
Prior - 2016

Doris Duke Charitable Foundation Established in 1996, the foundation supports four national grant-making programs. It also supports three properties that were owned by Doris Duke in Hillsborough, New Jersey; Honolulu, Hawaii; and Newport, Rhode Island. The foundation is headquartered in New York and is governed by a board of 12 Trustees. DDCF's activities are guided by the will of Doris Duke, who endowed the foundation with financial assets that totaled approximately $1.6 billion as of December 31, 2012. The foundation regularly evaluates and modifies its allocation of resources from the endowment to support the programs and properties and to respond to fluctuations in portfolio returns. The foundation awarded its first grants in 1997. As of December 31, 2012, the foundation has awarded grants totaling approximately $1.1 billion. - See more at: http://www.ddcf.org/About-Us/#sthash.ASPCjkw9.dpuf

Director
Tenure Unconfirmed
Director
Tenure Unconfirmed
Awards & Honors
1961
Board Certification - American Board of Pathology
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Harry B. Demopoulos. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Harry B. Demopoulos's profile does not indicate a business or promotional relationship of any kind between RelSci and Harry B. Demopoulos.